Hypothyroidism and Dermato/polymyositis: a Two-sample Mendelian Randomization Study

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2024 Sep 19

PMID 39296720

Authors

Qianqian Li

Shaoying Yang

Yan Ma

Huijing Huang

Langxian Zhi

Suli Wang

Liangjing Lu

Affiliations

Soon will be listed here.

Abstract

Objective: Observational studies have revealed a higher probability of hypothyroidism in patients with dermatomyositis (DM) or polymyositis (PM), but there is no consensus on whether hypothyroidism causally influences DM or PM. In the present study, we assessed the causal association between hypothyroidism and the risk of dermatomyositis or polymyositis using two-sample Mendelian randomization (TSMR).

Methods: The genome-wide association data of hypothyroidism and dermatomyositis/polymyositis were obtained from the IEU Open GWAS project. Then, TSMR was used to determine whether hypothyroidism is causally associated with DM or PM. Single-nucleotide polymorphisms (SNPs) significantly associated with hypothyroidism were identified and used as instrumental variables (IVs), and the causal relationship between hypothyroidism and DM/PM was examined using TSMR. MR pleiotropy and Cochran's Q test were used to confirm the heterogeneity and pleiotropy of identified IVs, then four different models, including the inverse variance weighted model (IVW), MR-Egger, weighted median and weighted model were applied in this MR analysis.

Results: Sixty-eight SNPs for DM and 68 SNPs for PM were selected as the IVs (P<5×10; linkage disequilibrium R <0.001) to assess the causal association between hypothyroidism and DM/PM selected from GWASs on hypothyroidism. The results revealed a positive causal effect of hypothyroidism on both DM and PM (DM: OR 2.563, 95% CI [1.348, 4.874], P = 0.00156; PM: OR1.709, 95% CI [1.157, 2.525], P =0.007). Moreover, there was no heterogeneity or pleiotropy in the results.

Conclusion: In conclusion, the MR analysis results provided strong evidence to indicate that hypothyroidism might be causally associated with DM and PM. These findings may have important implications for the pathogenesis and possible future therapies of DM/PM.

References

Bowden J, Hemani G, Davey Smith G . Invited Commentary: Detecting Individual and Global Horizontal Pleiotropy in Mendelian Randomization-A Job for the Humble Heterogeneity Statistic?. Am J Epidemiol. 2018; 187(12):2681-2685. PMC: 6269239. DOI: 10.1093/aje/kwy185. View

Gamsky T, Chan M . Coexistent dermatomyositis and autoimmune thyroiditis. West J Med. 1988; 148(2):213-4. PMC: 1026074. View

Wang H, Tao L, Li H, Deng J . Dermatomyositis related to autoimmune thyroiditis. J Eur Acad Dermatol Venereol. 2010; 25(9):1085-93. DOI: 10.1111/j.1468-3083.2010.03929.x. View

Richardson T, Sanderson E, Elsworth B, Tilling K, Davey Smith G . Use of genetic variation to separate the effects of early and later life adiposity on disease risk: mendelian randomisation study. BMJ. 2020; 369:m1203. PMC: 7201936. DOI: 10.1136/bmj.m1203. View

Nagy E, SZODORAY L, Pongracz E . [Simultaneous presence of Hashimoto's goiter, dermatomyositis and scleromyxedema]. Z Haut Geschlechtskr. 1962; 33:26-9. View

Lukjanowicz M, Bobrowska-Snarska D, Brzosko M . [Coexistence of hypothyroidism with polymyositis or dermatomyositis]. Ann Acad Med Stetin. 2007; 52 Suppl 2:49-55. View

Dalakas M, Hohlfeld R . Polymyositis and dermatomyositis. Lancet. 2003; 362(9388):971-82. DOI: 10.1016/S0140-6736(03)14368-1. View

Wang H, Li H, Kai C, Deng J . Polymyositis associated with hypothyroidism or hyperthyroidism: two cases and review of the literature. Clin Rheumatol. 2010; 30(4):449-58. DOI: 10.1007/s10067-010-1570-8. View

Charalabopoulos K, Mittari E, Peschos D, Golias C, Charalabopoulos A, Tsanou E . Rare association of chronic lymphocytic thyroiditis with dermatomyositis. Arch Med Res. 2006; 37(4):563-5. DOI: 10.1016/j.arcmed.2005.11.001. View

10.

Dong S, Zhang K, Guo Y, Ding J, Rong Y, Feng J . Phenome-wide investigation of the causal associations between childhood BMI and adult trait outcomes: a two-sample Mendelian randomization study. Genome Med. 2021; 13(1):48. PMC: 8004431. DOI: 10.1186/s13073-021-00865-3. View

11.

Fois A, Paliogiannis P, Sotgia S, Mangoni A, Zinellu E, Pirina P . Evaluation of oxidative stress biomarkers in idiopathic pulmonary fibrosis and therapeutic applications: a systematic review. Respir Res. 2018; 19(1):51. PMC: 5872514. DOI: 10.1186/s12931-018-0754-7. View

12.

Bloise F, Cordeiro A, Ortiga-Carvalho T . Role of thyroid hormone in skeletal muscle physiology. J Endocrinol. 2017; 236(1):R57-R68. DOI: 10.1530/JOE-16-0611. View

13.

Simonides W, Thelen M, van der Linden C, Muller A, van Hardeveld C . Mechanism of thyroid-hormone regulated expression of the SERCA genes in skeletal muscle: implications for thermogenesis. Biosci Rep. 2001; 21(2):139-54. DOI: 10.1023/a:1013692023449. View

14.

Denny J, Bastarache L, Ritchie M, Carroll R, Zink R, Mosley J . Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data. Nat Biotechnol. 2013; 31(12):1102-10. PMC: 3969265. DOI: 10.1038/nbt.2749. View

15.

Burgess S, Thompson S . Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017; 32(5):377-389. PMC: 5506233. DOI: 10.1007/s10654-017-0255-x. View

16.

Kiss E, Jakab G, Kranias E, Edes I . Thyroid hormone-induced alterations in phospholamban protein expression. Regulatory effects on sarcoplasmic reticulum Ca2+ transport and myocardial relaxation. Circ Res. 1994; 75(2):245-51. DOI: 10.1161/01.res.75.2.245. View

17.

Zampieri S, Valente M, Adami N, Biral D, Ghirardello A, Rampudda M . Polymyositis, dermatomyositis and malignancy: a further intriguing link. Autoimmun Rev. 2009; 9(6):449-53. DOI: 10.1016/j.autrev.2009.12.005. View

18.

Selva-OCallaghan A, Redondo-Benito A, Trallero-Araguas E, Martinez-Gomez X, Palou E, Vilardell-Tarres M . Clinical significance of thyroid disease in patients with inflammatory myopathy. Medicine (Baltimore). 2007; 86(5):293-298. DOI: 10.1097/MD.0b013e318156f9c2. View

19.

Burgess S, Daniel R, Butterworth A, Thompson S . Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways. Int J Epidemiol. 2014; 44(2):484-95. PMC: 4469795. DOI: 10.1093/ije/dyu176. View

20.

Mastruzzo C, Crimi N, Vancheri C . Role of oxidative stress in pulmonary fibrosis. Monaldi Arch Chest Dis. 2003; 57(3-4):173-6. View